The American Journal of Medicine
Volume 123, Issue 7 , Pages 631-637, July 2010

The Value of Infectious Diseases Consultation in Staphylococcus aureus Bacteremia

  • Hitoshi Honda, MD

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Mo
    • Corresponding Author InformationReprint requests should be addressed to Hitoshi Honda, MD, 660 South Euclid Avenue, Campus Box 8051, St Louis, MO 63110
  • ,
  • Melissa J. Krauss, MPH

      Affiliations

    • Division of Biostatistics, Department of Medicine, Washington University School of Medicine, St Louis, Mo
  • ,
  • Jeffrey C. Jones, MD

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Mo
  • ,
  • Margaret A. Olsen, PhD, MPH

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Mo
  • ,
  • David K. Warren, MD, MPH

      Affiliations

    • Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Mo

published online 20 May 2010.

Abstract 

Background

Staphylococcus aureus bacteremia results in substantial mortality. Infectious diseases specialist consultation can improve adherence to evidence-based management of S. aureus bacteremia, but its effect on mortality is unclear.

Methods

A 2-year prospective cohort study of patients with S. aureus bacteremia was performed at a large tertiary care hospital. Patients who died within 2 days of diagnosis were excluded. Independent risk factors for 28-day mortality were determined.

Results

Among 341 patients with S. aureus bacteremia, 189 (55%) were male, 196 (58%) were Caucasian, 185 (54%) had methicillin-resistant S. aureus, 108 (32%) had nosocomial bacteremia, and 231 (68%) had a central venous catheter at the time of diagnosis. The median age was 56 years (range 22-95 years). A total of 111 patients (33%) had an infectious diseases consultation. Fifty-four patients (16%) died within 28 days after diagnosis. Factors associated with mortality were intensive care unit admission 48 hours or less after the first positive blood culture (adjusted hazard ratio, 4.65; 95% confidence interval [CI], 2.65-8.18), cirrhosis (adjusted hazard ratio, 4.44; 95% CI, 2.40-8.20), and advanced age (adjusted hazard ratio, 1.27 per every 10 years of age; 95% CI, 1.08-1.50). Infectious diseases consultation was associated with a 56% reduction in 28-day mortality (adjusted hazard ratio, 0.44; 95% CI, 0.22-0.89).

Conclusion

Only one third of patients with S. aureus bacteremia in this cohort had an infectious diseases specialist consultation. Infectious diseases consultation was independently associated with a reduction in 28-day mortality. Routine infectious diseases consultation should be considered for patients with S. aureus bacteremia, especially those with greater severity of illness or multiple comorbidities.

Keywords: Infectious diseases consultation, Mortality, Staphylococcus aureus bacteremia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding: Centers for Disease Control and Prevention Epicenter (5U01CI000033302). MJK is funded by the National Center for Research Resources, a component of the National Institutes of Health and National Institutes of Health Roadmap for Medical Research (UL1 RR024992).

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(10)00128-2

doi:10.1016/j.amjmed.2010.01.015

The American Journal of Medicine
Volume 123, Issue 7 , Pages 631-637, July 2010